PCM
MBII

Prelude Capital Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Prelude Capital Management’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,705
Closed -$14K – 2196
2022
Q2 		$14K Buy
+11,705
New +$12.2K ﹤0.01% 1556

Prelude Capital Management's MBII Position: Q3 2022 in Review

Prelude Capital Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 11,705 shares — an estimated $14K sold.

Prelude Capital Management first reported a position in MBII in Q2 2022 and held it in 1 quarter. The position peaked at $14K in Q2 2022. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

  • Prelude Capital Management reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
  • Prelude Capital Management sold 11,705 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $14K.
  • Prelude Capital Management first reported a position in Marrone Bio Innovations, Inc. in Q2 2022 and held it in 1 quarter.
  • Prelude Capital Management's Marrone Bio Innovations, Inc. position peaked at $14K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Prelude Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.